Skip to main content
ASIX $17.04 +3.09%
ASIX logo

ASIX · AdvanSix Inc.

Track ASIX — free
$17.04 +0.51 (+3.09%) At close · Aug 14
Market Cap
$459.56M
Shares
27.00M
All earnings calls

Earnings call · FY2024 Q1

AdvanSix Inc. Q1 FY2024 Earnings Call

AdvanSix Inc. Q1 FY2024 Earnings Call

Concluded May 3, 2024
May 3, 2024 60 turns
Period
FY2024 Q1
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Nylon market and spreads 25 Ammonium sulfate / plant nutrients 24 Chemical intermediates and acetone 17 Industry destocking 15 Sustainability and certifications 14 Operational disruption at Frankford 12

Management tone

Positive

Net tone +15 · moderate hedging

Grounding quotes
  • “Looking ahead to the second quarter and remainder of 2024, there are a number of operational and commercial tailwinds at our back.”
  • “Sales of $337 million decreased approximately 16% versus the prior year.”
  • “We anticipate debt leverage to remain within our target range of 1 times to 2.5 times in 2024.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $336.83M -15.9% YoY
Diluted EPS -$0.65 -153.3% YoY
Net income -$17.40M -149.8% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Capital expenditures
in 2024
$140M – $150M
Ammonium sulfate granular conversion
by the end of 2024
70%
Pretax income impact of planned plant turnarounds
in 2024
$38M – $43M
Effective tax rate Maintained
full year 2024
24%

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Chemical Intermediates$96.27M -16% YoY
Plant Nutrients$94.70M
Nylon Resins$84.39M -15.1% YoY
Caprolactam$61.48M -15.1% YoY

Capital returned

Buybacks
$7.02M
Shares repurchased
260,464
Dividend / share
$0.16
Full-screen source Call document